menu
    • menu

    Company profile for Reliance Life Sciences Private Limited

    NEW Drugs in Dev: 2
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Guizhou Utide Biotechnology Co., Ltd. - Specialized GMP manufacturing for next-generation GLP-1 peptide APIs.

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    The Reliance Group is India’s largest private sector enterprise, with annual revenues of US$ 66.8 billion. The Group’s activities span oil and gas exploration and production, petroleum refining, petrochemicals, polyester, plastics, organized retailing and telecom. The Group’s flagship company Reliance Industries Limited is the largest private sector company and a Fortune Global 500 company. Reliance Life Sciences (RLS) ...
    The Reliance Group is India’s largest private sector enterprise, with annual revenues of US$ 66.8 billion. The Group’s activities span oil and gas exploration and production, petroleum refining, petrochemicals, polyester, plastics, organized retailing and telecom. The Group’s flagship company Reliance Industries Limited is the largest private sector company and a Fortune Global 500 company. Reliance Life Sciences (RLS) is part of the Reliance Group of companies. RLS was established to develop business opportunities in medical biotechnology with key initiatives in biopharmaceuticals, pharmaceuticals, regenerative medicine, etc.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Reliance Life Sciences Private Limitedindia-flag Flag
    Country
    Country
    India
    Address
    Address
    Dhirubhai Ambani Life Sciences Center,R-282, TTC Industrial Area of MIDC,Thane...
    Telephone
    Telephone
     91 (22) 6767 8000
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.rellife.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    Food Ingredients China

    Not Confirmed

    envelop Contact Supplier

    Food Ingredients China

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Pharma Inc sets sights on monkeypox vax
    Pharma Inc sets sights on monkeypox vax

    17 Aug 2022

    // HEALTH ECONOMICS TIMES

    https://health.economictimes.indiatimes.com/news/pharma/pharma-inc-sets-sights-on-monkeypox-vax/93603964

    HEALTH ECONOMICS TIMES
    17 Aug 2022
    Share Share
    CDSCO gives nod to Reliance for ph I study of its recombinant Covid-19 vaccine
    CDSCO gives nod to Reliance for ph I study of its recombinant Covid-19 vaccine

    27 Aug 2021

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=142137&sid=2

    PHARMABIZ
    27 Aug 2021
    Share Share
    Medicure announces an agreement with Reliance Life Sciences for marketing rights
    Medicure announces an agreement with Reliance Life Sciences for marketing rights

    05 Oct 2020

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/medicure-announces-an-agreement-with-reliance-life-sciences-for-the-marketing-rights-of-a-cardiovascular-biosimilar-301145432.html

    PRNEWSWIRE
    05 Oct 2020
    Share Share
    Netmeds to complement RIL's digital consultation, diagnostic test offering
    Netmeds to complement RIL's digital consultation, diagnostic test offering

    19 Aug 2020

    // ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/netmeds-to-complement-rils-digital-consultation-diagnostic-test-offering-say-analysts/articleshow/77633215.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

    ECONOMICTIMES
    19 Aug 2020
    Share Share
    Reliance Life gains global rights for copies of Infliximab
    Reliance Life gains global rights for copies of Infliximab

    26 Jul 2016

    // ECONOMIC TIMES

    http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/reliance-life-gains-global-rights-for-copies-of-infliximab/articleshow/53389127.cms

    ECONOMIC TIMES
    26 Jul 2016
    Share Share
    Reliance Life Sciences appeals marketing restrictions on breast cancer drug
    Reliance Life Sciences appeals marketing restrictions on breast cancer drug

    04 Jun 2016

    // Prabha Raghavan ECONOMIC TIMES

    http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/reliance-life-sciences-appeals-marketing-restrictions-on-breast-cancer-drug/articleshow/52573871.cms

    Prabha Raghavan ECONOMIC TIMES
    04 Jun 2016
    Share Share

    ALL APIs

    read-moreClick the button for full data set
    read-moreClick the button for full data set

    01

    Bortezomib

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    RNA Leaders Europe
    Not Confirmed
    arrow

    Bortezomib

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    RNA Leaders Europe
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down Click Us! arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2018-07-06

    Pay. Date : 2018-03-28

    DMF Number : 26282

    Submission : 2012-08-14

    Status : Active

    Type : II

     CEP/COS JDMF EU-WCInactive-api
    ✖

    Date of Issue : 2022-08-31

    Valid Till : 2025-07-20

    Written Confirmation Number : WC-0198N

    Address of the Firm :

    NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Capecitabine

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    RNA Leaders Europe
    Not Confirmed
    arrow

    Capecitabine

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    RNA Leaders Europe
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2016-09-14

    Pay. Date : 2016-06-15

    DMF Number : 23808

    Submission : 2010-05-25

    Status : Active

    Type : II

     CEP/COS JDMF EU-WCInactive-api
    ✖

    Date of Issue : 2022-08-31

    Valid Till : 2025-07-20

    Written Confirmation Number : WC-0198N

    Address of the Firm :

    NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Dasatinib

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    RNA Leaders Europe
    Not Confirmed
    arrow

    Dasatinib

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    RNA Leaders Europe
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 31169

    Submission : 2017-03-30

    Status : Active

    Type : II

     CEP/COS JDMF EU-WCInactive-api
    ✖

    Date of Issue : 2022-08-31

    Valid Till : 2025-07-20

    Written Confirmation Number : WC-0198N

    Address of the Firm :

    NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Decitabine

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    RNA Leaders Europe
    Not Confirmed
    arrow

    Decitabine

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    RNA Leaders Europe
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2022-06-09

    Pay. Date : 2022-05-23

    DMF Number : 29832

    Submission : 2016-12-08

    Status : Active

    Type : II

     CEP/COS JDMF EU-WCInactive-api
    ✖

    Date of Issue : 2022-08-31

    Valid Till : 2025-07-20

    Written Confirmation Number : WC-0198N

    Address of the Firm :

    NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    Erlotinib Hydrochloride

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    RNA Leaders Europe
    Not Confirmed
    arrow

    Erlotinib Hydrochloride

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    RNA Leaders Europe
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2021-03-05

    Pay. Date : 2021-01-20

    DMF Number : 25978

    Submission : 2012-05-16

    Status : Active

    Type : II

     CEP/COS JDMF EU-WCInactive-api
    ✖

    Date of Issue : 2022-08-31

    Valid Till : 2025-07-20

    Written Confirmation Number : WC-0198N

    Address of the Firm :

    NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    Imatinib Mesylate

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    RNA Leaders Europe
    Not Confirmed
    arrow

    Imatinib Mesylate

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    RNA Leaders Europe
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 24207

    Submission : 2011-03-04

    Status : Active

    Type : II

     CEP/COS JDMF EU-WCInactive-api
    ✖

    Date of Issue : 2022-08-31

    Valid Till : 2025-07-20

    Written Confirmation Number : WC-0198N

    Address of the Firm :

    NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    Lenalidomide

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    RNA Leaders Europe
    Not Confirmed
    arrow

    Lenalidomide

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    RNA Leaders Europe
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2023-03-23

    Pay. Date : 2023-02-13

    DMF Number : 27905

    Submission : 2014-02-03

    Status : Active

    Type : II

     CEP/COS JDMF EU-WCInactive-api
    ✖

    Date of Issue : 2022-08-31

    Valid Till : 2025-07-20

    Written Confirmation Number : WC-0198N

    Address of the Firm :

    NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    08

    Pemetrexed Disodium

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    RNA Leaders Europe
    Not Confirmed
    arrow

    Pemetrexed Disodium

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    RNA Leaders Europe
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2013-09-27

    Pay. Date : 2013-02-20

    DMF Number : 25559

    Submission : 2012-03-15

    Status : Active

    Type : II

     CEP/COS JDMF EU-WCInactive-api
    ✖

    Date of Issue : 2022-08-31

    Valid Till : 2025-07-20

    Written Confirmation Number : WC-0198N

    Address of the Firm :

    NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    09

    Sorafenib

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    RNA Leaders Europe
    Not Confirmed
    arrow

    Sorafenib

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    RNA Leaders Europe
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 28556

    Submission : 2014-09-23

    Status : Active

    Type : II

     CEP/COS JDMF EU-WCInactive-api
    ✖

    Date of Issue : 2022-08-31

    Valid Till : 2025-07-20

    Written Confirmation Number : WC-0198N

    Address of the Firm :

    NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    10

    Sunitinib

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    RNA Leaders Europe
    Not Confirmed
    arrow

    Sunitinib

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    RNA Leaders Europe
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2022-10-28

    Pay. Date : 2022-09-23

    DMF Number : 29014

    Submission : 2015-03-04

    Status : Active

    Type : II

     CEP/COS JDMF EU-WCInactive-api
    ✖

    Date of Issue : 2022-08-31

    Valid Till : 2025-07-20

    Written Confirmation Number : WC-0198N

    Address of the Firm :

    NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Reliance Life Sciences Private Limited and get a quotation

    Reliance Life Sciences Private Limited is a supplier offers 18 products (APIs, Excipients or Intermediates).

    Find a price of Bortezomib bulk with DMF offered by Reliance Life Sciences Private Limited

    Find a price of Capecitabine bulk with DMF offered by Reliance Life Sciences Private Limited

    Find a price of Dasatinib bulk with DMF offered by Reliance Life Sciences Private Limited

    Find a price of Decitabine bulk with DMF offered by Reliance Life Sciences Private Limited

    Find a price of Erlotinib Hydrochloride bulk with DMF offered by Reliance Life Sciences Private Limited

    Find a price of Imatinib Mesylate bulk with DMF offered by Reliance Life Sciences Private Limited

    Find a price of Lenalidomide bulk with DMF offered by Reliance Life Sciences Private Limited

    Find a price of Pemetrexed Disodium bulk with DMF offered by Reliance Life Sciences Private Limited

    Find a price of Sorafenib bulk with DMF offered by Reliance Life Sciences Private Limited

    Find a price of Sunitinib bulk with DMF offered by Reliance Life Sciences Private Limited

    Find a price of Temozolomide bulk with DMF offered by Reliance Life Sciences Private Limited

    Find a price of Azacitidine bulk with DMF offered by Reliance Life Sciences Private Limited

    Find a price of Lanreotide Acetate bulk with DMF offered by Reliance Life Sciences Private Limited

    Find a price of Dutasteride bulk offered by Reliance Life Sciences Private Limited

    Find a price of Eszopiclone bulk offered by Reliance Life Sciences Private Limited

    Find a price of Loteprednol Etabonate bulk offered by Reliance Life Sciences Private Limited

    Find a price of Nandrolone Decanoate bulk offered by Reliance Life Sciences Private Limited

    Find a price of Rocuronium Bromide bulk offered by Reliance Life Sciences Private Limited

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search